In ER-positive BC patients, EGR1/3 expression levels were significantly upregulated (p < 0.0001), while EGR2/4 expression levels were significantly downregulated (EGR2: p = 0.0104, EGR4: p < 0.0001). This evidence concerns the gene EGR2 and breast cancer.